4//SEC Filing
McManus John L 4
Accession 0001102624-12-000584
CIK 0001261734other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 9:16 PM ET
Size
5.8 KB
Accession
0001102624-12-000584
Insider Transaction Report
Form 4
MCMANUS JOHN L
President & CEO
Transactions
- Award
Non-qualified Stock Option (right to buy)
2012-07-14+250,000→ 250,000 totalExercise: $0.28Exp: 2022-07-14→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]Options will vest at a rate of 20,833 shares per month over a period of twelve months from the date of grant, provided that John L. McManus is an employee or consultant of the Issuer on the applicable vesting date. In the event of a sale of the Issuer, through a merger or otherwise, all of the options shall be fully vested and immediately exercisable.
Documents
Issuer
AEOLUS PHARMACEUTICALS, INC.
CIK 0001261734
Entity typeother
Related Parties
1- filerCIK 0001193923
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 9:16 PM ET
- Size
- 5.8 KB